Mary-Jane Burkett
Director of Finance/CFO at NUVO PHARMACEUTICALS INC.
Mary-Jane Burkett active positions
| Companies | Position | Start | End |
|---|---|---|---|
| NUVO PHARMACEUTICALS INC. | Director of Finance/CFO | 01/09/2016 | - |
| Comptroller/Controller/Auditor | 01/01/2012 | 01/09/2016 |
Career history of Mary-Jane Burkett
Former positions of Mary-Jane Burkett
| Companies | Position | Start | End |
|---|---|---|---|
| CRESCITA THERAPEUTICS INC. | Comptroller/Controller/Auditor | - | - |
Training of Mary-Jane Burkett
| Richard Ivey School of Business | Undergraduate Degree |
Statistics
International
| Canada | 3 |
| Hong Kong | 2 |
Operational
| Comptroller/Controller/Auditor | 2 |
| Director of Finance/CFO | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| CRESCITA THERAPEUTICS INC. | Health Technology |
| Private companies | 1 |
|---|---|
Nuvo Pharmaceuticals, Inc.
 Nuvo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Nuvo Pharmaceuticals, Inc. is a pharmaceutical company, which is engaged in developing innovative therapeutic pharmaceutical products. It operates through the following segments: Commercial Business, Production and Service Business, and Licensing and Royalty Business. The Commercial Business segment includes Blexten, Cambia, the canadian business for Resultz and Suvexx, and mature assets. The Production and Service Business segment supplies Pennsaid to Horizon for the U.S. market and is engaged in ongoing partnering efforts for Pennsaid. The Licensing and Royalty Business segment engages in the selling of Vimovo. The company was founded on August 22, 1983 and is headquartered in Mississauga, Canada. | Health Technology |
- Stock Market
- Insiders
- Mary-Jane Burkett
- Experience
